Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure

T Gombos, Z Förhécz, Z Pozsonyi, G Széplaki… - Clinical Research in …, 2012 - Springer
Objectives The purpose of this study was to evaluate complement activation in a heart failure
cohort. Based on their powerful biological activity, we hypothesized that the levels of …

Soluble CXCL16 predicts long-term mortality in acute coronary syndromes

AM Jansson, P Aukrust, T Ueland, C Smith, T Omland… - Circulation, 2009 - Am Heart Assoc
Background—CXCL16/SR-PSOX is an interferon-γ–regulated chemokine and scavenger
receptor for oxidized low-density lipoprotein that is expressed in atherosclerotic lesions …

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP‐1 and MMP‐9 in human macrophages in vitro

WS Speidl, SP Kasd, R Hutter, KM Katsaros… - The FASEB …, 2011 - Wiley Online Library
The complement component C5a is formed during activation of the complement cascade
and exerts chemotactic and proinflammatory effects. Macrophages, which are localized in …

CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events

SCA de Jager, AO Kraaijeveld, RW Grauss… - Journal of molecular and …, 2008 - Elsevier
As chemokines are considered instrumental in thrombotic plaque rupture and erosion as
well as in ischemia-reperfusion injury processes, we aimed to identify previously unknown …

CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis

A Shamsi, SA Roghani, P Soufivand, M Pournazari… - Clinical …, 2024 - Springer
Introduction Cardiovascular disease (CVD) is the most critical extra-articular manifestation of
rheumatoid arthritis, and inflammatory molecules contribute to its pathogenesis. Recently …

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

JA de Lemos, DA Morrow, MS Sabatine, SA Murphy… - Circulation, 2003 - Am Heart Assoc
Background—Monocyte chemoattractant protein-1 (MCP-1) is a chemokine responsible for
the recruitment of monocytes to sites of inflammation. MCP-1 appears to play a critical role at …

Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes

M Fiechter, JR Ghadri, M Jaguszewski… - Journal of …, 2013 - journals.lww.com
Aims Inflammation is a key factor in the long-term outcome of acute coronary syndromes
(ACS). The aim of the present study was to evaluate inflammatory markers in patients with …

Predictive value of Serum CCL21 and CCL19 levels in heart failure patients: A prospective study

W Zeng, L Li, L Wang, B Lin, K Lin, P Yu, H Yu - medRxiv, 2023 - medrxiv.org
Background: Chemokine CC motif ligand (CCL) 21 and CCL19 are well-recognized to
associate with adverse events of cardiovascular disease, especially long-term prognosis …

[HTML][HTML] Increased complements and high‑sensitivity C‑reactive protein predict heart failure in acute myocardial infarction

D Liu, X Qi, Q Li, W Jia, L Wei… - Biomedical …, 2016 - spandidos-publications.com
The aim of the present study was to investigate whether the serum levels of complements
and high‑sensitivity C‑reactive protein (hs‑CRP) in patients with acute myocardial infarction …

[引用][C] Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease

KE Kluge, MS Langseth, V Bratseth… - Thrombosis …, 2020 - thrombosisresearch.com
The complement and coagulation systems are both cascades consisting of inactive,
circulating precursor proteins. The complement system is a part of the innate immune …